scholarly journals SURGICAL STRATEGY AGAINST ARTERIOSCLEROSIS OBLITERANCE OR ABDOMINAL AORTIC ANEURYSM WITH ISCHEMIC HEART DISEASE

1997 ◽  
Vol 58 (5) ◽  
pp. 964-968
Author(s):  
Masahiro YOSHIDA ◽  
Kazuhiro YOSHII ◽  
Hayazo KUBO ◽  
Hiroshi KOHNOSU ◽  
Shuji SHIRAKATA ◽  
...  
1995 ◽  
Vol 24 (1) ◽  
pp. 31-35
Author(s):  
Hiroshi Urayama ◽  
Kenji Kawakami ◽  
Fuminori Kasashima ◽  
Yuhshi Kawase ◽  
Takeshi Harada ◽  
...  

1996 ◽  
Vol 25 (3) ◽  
pp. 165-169
Author(s):  
Kiyoshi Inoue ◽  
Soichiro Kitamura ◽  
Kanji Kawachi ◽  
Tetsuji Kawata ◽  
Shuichi Kobayashi ◽  
...  

Surgery Today ◽  
2003 ◽  
Vol 33 (8) ◽  
pp. 612-616 ◽  
Author(s):  
Hideaki Manabe ◽  
Hisato Takagi ◽  
Yoshio Mori ◽  
Hisashi Iwata ◽  
Kenichi Sakamoto ◽  
...  

2004 ◽  
Vol 33 (2) ◽  
pp. 73-76
Author(s):  
Atsushi Yamaguchi ◽  
Ken-ichiro Noguchi ◽  
Hideo Adachi ◽  
Koji Kawahito ◽  
Sei-ichiro Murata ◽  
...  

2005 ◽  
Vol 20 (4) ◽  
pp. 167-170 ◽  
Author(s):  
Takayoshi Kato ◽  
Hisato Takagi ◽  
Yoshio Mori ◽  
Ken-ichi Sakamoto ◽  
Takuya Yamada ◽  
...  

2017 ◽  
Vol 51 (5) ◽  
pp. 274-281 ◽  
Author(s):  
Gerard M. Healy ◽  
Ciaran E. Redmond ◽  
Sam Gray ◽  
Lucian Iacob ◽  
Stephen Sheehan ◽  
...  

Purpose: To assess rates of complications, secondary interventions, survival, and cause of death following endovascular abdominal aortic aneurysm (AAA) repair over a 10-year period. Materials and Methods: Single-institution retrospective cohort study of all patients undergoing primary endovascular aortic aneurysm repair (EVAR) between July 2006 and June 2015. The population constituted 175 patients with 163 fusiform and 12 saccular AAAs. Of these, 149 (85%) were male, with mean age 75.4 (±7.1) years. Patients were followed up until June 30, 2016. Cause of death was determined from the national death register. Results: Mean follow-up was 34.4 (±24.4) months. The secondary intervention rate was 9.7%, and there were 4 aneurysm ruptures (0.8% annual incidence). Thirty-day mortality was 0.6%. Survival at 1, 3, and 5 years was 93.1%, 84%, and 64.9%, respectively. Forty-eight patients died during follow-up, 3 secondary to rupture, leading to overall and aneurysm-related death rates of 9.7 and 0.6 per 100 person-years. All other deaths were due to nonaneurysm causes, most commonly cardiovascular (n = 15), pulmonary (n = 13), and malignancy (n = 9). Baseline renal impairment ( P < .001), ischemic heart disease ( P < .05), age greater than 75 years ( P < .05), and urgent/emergency EVAR were associated with inferior long-term survival. Type II endoleak negatively influenced fusiform aneurysm sac regression ( P = .02), but there was no association between survival and occurrence of any complication or secondary intervention. Conclusion: The majority of deaths during medium-term follow-up post-EVAR are due to nonaneurysm-related causes. Survival is determined by the following baseline factors: renal impairment, ischemic heart disease, advanced age, and the presence of a symptomatic/ruptured aneurysm.


Sign in / Sign up

Export Citation Format

Share Document